Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

Storytel goes live in Belgium today

Today Storytel, one of the world’s largest streaming services for audiobooks and e-books, goes live in Belgium. The launch strengthens Storytel’s presence in the Benelux region and will include extensive marketing initiatives in Belgium, including TV advertisements as well as social media and online campaigns.On 24 September, Storytel announced its expansion to Belgium launching a local service operated by Storytel Netherlands. Belgian subscribers will from day one have access to more than 250 000 audiobooks and e-books in a catalogue featuring both international bestsellers and strong

BioStock: Bayer acquires gene therapy company AskBio in billion-dollar deal

The pace of development in gene therapies has accelerated; new treatments are on the way and the interest from investors and the life science sector has certainly not diminished. The area has now received further attention with Bayer’s acquisition of Asklepios BioPharmaceuticals, which was announced on Monday. The purchase price amounted to two billion USD and another two billion when agreed milestones are reached.Read the full article on the gene therapy deal at biostock.se: https://www.biostock.se/en/bayer-acquires-gene-therapy-company-askbio-in-billion-dollar-deal/ This is a

Leadership. Nordic strength areas. Asian business logic. Programme start for Gothenburg Executive MBA 2020–2022

Early October, the Executive MBA programme 2020–2022 started at the School of Business, Economics and Law at the University of Gothenburg. Over 21 months, the 16 participating leaders will develop a wide range of skills and capabilities to prepare them for more extensive business responsibilities and developed leadership capabilities in a rapidly changing, global world. The part-time education is delivered in English and has a special focus on the Nordic countries and Asia. The lecturers come from the School of Business, Economics and Law and its partner universities around the world.

Nomination committee appointed ahead of 2021 Annual General Meeting of Pricer AB

Pricer AB (publ) has appointed the nomination committee ahead of the 2021 Annual General Meeting.In accordance with the decision at the Annual General Meeting on May 6, 2020 Pricer’s Chairman of the Board Knut Faremo has contacted the company’s three largest shareholders to form a Nomination Committee. Shareholders shall also include such a group of two or more shareholders who have notified the Chairman of the Board that they wish to participate jointly in the Nomination Committee's work. The shareholders and representatives comprising the Nomination Committee are:– Jari Ekblad,

Immunovia to Host Webinar Introducing New CEO, Patrik Dahlen

LUND, SWEDEN – Immunovia, a diagnostic company that develops highly accurate blood tests for the early detection of cancer and autoimmune diseases, today announced that the company will host a webinar to introduce incoming CEO, Patrik Dahlen on Tuesday, November 3[rd], 2020 at 9:00 CET. The webinar will include a Q&A session with CEO, Patrik Dahlen and Chairman, Carl Borrebaeck. Immunovia previously announced the CEO transition on August 26[th], 2020 (link to press release ). Patrik

Africa Oil Announces Second Significant Discovery on Block 11B/12B Offshore South Africa

VANCOUVER, October 28, 2020 /CNW/ - (AOI–TSX, AOI–Nasdaq-Stockholm) – Africa Oil Corp. (“AOI”, “Africa Oil” or “the Company”) is pleased to announce a significant gas condensate discovery on the Luiperd prospect located on Block 11B/12B offshore South Africa. This discovery follows the adjacent play-opening Brulpadda discovery in 2019, which proved a significant new petroleum province in the region. The Company holds an indirect interest in the project as a result of its equity interests in Africa Energy (31.3%) and Impact Oil & Gas Limited (31.1%). Garrett Soden, Africa Energy’s

Africa Energy Announces Second Significant Discovery Offshore South Africa

VANCOUVER, BC, October 28, 2020 /CNW/ – Africa Energy Corp. (TSX Venture: AFE, Nasdaq First North Growth Market: AEC) (“Africa Energy” or the “Company”), an oil and gas company with exploration assets offshore South Africa and Namibia, is pleased to announce a significant gas condensate discovery on the Luiperd prospect located on Block 11B/12B offshore South Africa. This discovery follows the adjacent play-opening Brulpadda discovery in 2019, which proved a significant new petroleum province in the region. Garrett Soden, Africa Energy’s President and CEO, commented, “We are thrilled to

Pekka Vauramo to continue as President and CEO of Metso Outotec until the end of 2023

Metso Outotec Corporation’s stock exchange release on October 28, 2020, at 09:10 a.m. EETPekka Vauramo will continue as the President and CEO of Metso Outotec until the end of 2023. “This is a unique opportunity to lead the integration of the two great companies into Metso Outotec and to develop Metso Outotec to become an industry leader. We are in the beginning of our integration journey and Metso Outotec has a lot of potential to increase the effectiveness of its operations and to serve its customers even better and in a more sustainable way,” says Pekka Vauramo.   “I´m pleased that

Finnair’s financial calendar and AGM in 2021

Finnair Plc          Stock Exchange Release           28 October 2020 at 9.05 EET A bulletin on Finnair Plc’s financial statements for 2020 will be published on Thursday 18 February 2021 at 09:00 a.m. EET. The financial statements 2020 will be published later the same day. The Annual General Meeting will be held on Wednesday 17 March 2021 at 3:00 p.m. EET in Helsinki. An official invitation to the meeting will be published later. The full financial calendar 2021 is as follows: · Financial Statements Bulletin for 2020 on Thursday 18 February 2021 · Interim Report for January–

Metso Outotec publishes its new strategy and financial targets

Metso Outotec Corporation’s stock exchange release on October 28, 2020, at 09:05 a.m. EETMetso Outotec, created through the combination of Metso Minerals and Outotec on June 30, 2020, has published its new strategy focusing on growth and improving profitability. The company aims to become a top-tier supplier of products, technologies and services in the aggregates and minerals industries and a top financial performer. Metso Outotec’s defined purpose is: “enabling sustainable modern life.”    Metso Outotec’s strong foundation for implementing its strategy and achieving its goals is

Ports Group chooses 700 square meters on Kungsgatan in Gothenburg

Ports Group, which is a market-leading company in brand security, has signed a lease with Wallenstam and is moving its headquarters from Mölnlycke to central Gothenburg. In January next year, it is moving into new premises of just over 700 square meters in order to increase its presence and accessibility in the middle of the city.“We are really looking forward to our move to new, modern premises in central Gothenburg. As a company, we protect brands – legally, digitally and technically and thereby create brand security in all areas of our customers’ brands. An attractive address as well as

Enhertu granted Priority Review in the US for the treatment of HER2-positive metastatic gastric cancer

28 October 2020 07:00 GMT Enhertu granted Priority Review in the US for thetreatment of HER2-positive metastatic gastric cancer Only HER2-directed medicine to demonstrate significant improvement in overall survival compared to chemotherapy for previously treated patients in this setting AstraZeneca and Daiichi Sankyo Company, Limited (Daiichi Sankyo)'s Enhertu (trastuzumab deruxtecan) has received acceptance for its supplemental Biologics License Application (sBLA) and has also been granted Priority Review in the US for the treatment of patients with HER2-positive metastatic

Invitation to presentation of Balco’s third quarter report 2020

Växjö, 28 October 2020Balco’s interim report for the third quarter 2020 will be published at 07:30 CET on November 12, 2020. A web-cast telephone conference will be held at 09:00 CET the same day, where CEO and President Kenneth Lundahl and CFO Michael Grindborn will present the results for the third quarter 2020. A possibility will be given to ask questions via the webcast and follow the presentation material live. The webcast, which afterwards also will be available on demand, will be accessible at Balco’s financial website, www.balcogroup.se or via the following link: https://tv.

Adapteo’s release date for the interim report January to September 2020 has been changed and is brought forward to 2 November

Adapteo Plc Press release 28 October 2020 at 8:00 a.m. CET Adapteo, a leading Northern European company for adaptable buildings, will publish its Business Review for January – September 2020 on Monday 2 November at approximately 07.30 CET. A conference call with a presentation for investors, analysts and media will be held at 09.00 CET the same day. The presentation will be held via teleconference and webcast by President & CEO Philip Isell Lind af Hageby and CFO Erik Skånsberg. The session will start with a presentation, followed by a question-and-answer session and will be held in

Forxiga cardiovascular outcomes benefit approved in China

28 October 2020 07:00 GMT Forxiga cardiovascular outcomes benefit approved in China Update to approval includes DECLARE-TIMI 58 Phase III trial that reduced the riskof composite of hospitalisation for heart failure or cardiovascular death in type-2 diabetes   China's National Medical Products Administration (NMPA) has updated the label for AstraZeneca's Forxiga (dapagliflozin) to include data from the DECLARE-TIMI 58 Phase III trial. DECLARE-TIMI 58 

UNION therapeutics appoints Dr. Kim Kjoeller as Chief Executive Officer and further strengthens leadership by appointing Dr. Günter Ditzinger as Chief Technology Officer

·UNION strengthens leadership following expansion of clinical pipeline from one to five later stage clinical candidates during 2020 · Dr. Kim Domela Kjoeller, Executive Vice President Global Research & Development at LEO Pharma A/S, has been appointed as new Chief Executive Officer with effect from January 1, 2021 · Dr. Günter Ditzinger, who holds 30 years of experience from Sanofi, Novartis and most recently as the Chief Technology Officer of Swiss-based Basilea Pharmaceutica, has been appointed as Chief Technology Officer  Hellerup, Denmark, October 28, 2020 – UNION

Interim Report July–September 2020: Record deliveries offset by a weaker market

LKAB has delivered a strong quarter with deliveries at a record high of 7.6 Mt. However, the effect on operating profit is offset by a lower dollar exchange rate, lower prices for highly upgraded iron ore products and increased costs.Net sales for the third quarter amounted to MSEK 9,333 (7,751), an increase of 20 percent compared with the same period last year. Operating profit decreased to MSEK 2,955 (3,128). The effect of high delivery volumes is offset by a lower dollar exchange rate, as well as lower prices for highly upgraded iron ore products and increased costs. The increased costs

Hexagon Interim Report 1 January - 30 September 2020

Third quarter 2020- Net sales decreased by -2 per cent to 939.9 MEUR (956.3). Using fixed exchange ratesand a comparable group structure (organic growth), net sales was unchanged by 0 per cent- Operating earnings (EBIT1) increased by 6 per cent to 250.1 MEUR (235.8)- Earnings before taxes, excluding non-recurring items, amounted to 242.2 MEUR (229.3)- Net earnings, excluding non-recurring items, amounted to 198.6 MEUR (188.0)- Earnings per share, excluding non-recurring items, amounted to 0.53 EUR (0.51)- Operating cash flow increased to 191.2 MEUR (167.5)- The Board of

Clavister Q3 2020: Revenue Growth of 39%, EBITDA Margin of 22%

October 28, 2020, Örnsköldsvik, Sweden. Clavister, a leader in high-performance cybersecurity solutions, released its third quarterly 2020 interim report today.  "Our third quarter of 2020 saw strong revenue growth of 39 %, record gross margin and an EBITDA margin of 22 %. I am really proud of the Clavister team and partners whom have remained fully operational and focused on delivering solutions to our customers despite the challenges due to the Covid-19 pandemic. The year to date results strengthen our confidence in delivering on our 2020 financial ambition of year-on-year improvements

Finnair Group Interim Report 1 January – 30 September 2020

Finnair Plc        Interim Report      28 October 2020 at 9.00 a.m. EET Heavy COVID-19 impact continued – Finnair implemented further cost reductions and took measures to improve the equity and cash position in line with its rebuild plan. July–September 2020 · Earnings per share were -0.15 euros (0.08)*. · Revenue decreased by 88.7% to 97.4 million euros (865.4). · The comparable operating result was -167.0 million euros (100.7). The operating result was -183.1 million euros (94.9). · Financial net expenses were 74.6 million euros (20.1) and they increased significantly,

Reminder: Invitation to presentation of Orkla’s third quarter 2020 results, Thursday 29 October

Orkla will report its third quarter 2020 results on Thursday, 29 October 2020 at 7.00 a.m. CET.The quarterly report and the presentation material will be available at this time at: https://investors.orkla.com.The results will be presented in a webcast with Presidet & CEO Jaan Ivar Semlitsch and CFO Harald Ullevoldsæter at 8.00 a.m. CET. As a consequence of the Corona situation, there will not be a physical presentation of the results.The presentation and subsequent Q&A session will be held in English and may be viewed live at https://investors.orkla.com (direct link: https://events.

Finnair increases its savings target to 140 million euros of permanent cost base reductions by 2022 onwards, superseding the previously announced target

Finnair Plc         Stock Exchange Release           28 October 2020 at 9.00 a.m. EET On 20 May 2020, Finnair announced that it was targeting nearly 80 million euros in permanent cost base reductions by 2022, compared to 2019 levels.  The company updated the same target in its announcement on 25 August 2020 by increasing it to c. 100 million euros.  Finnair has made good progress in the cost savings programme and has also identified new savings opportunities. As a result, Finnair has increased its savings target by 40 million euros, increasing its previous expectations for a permanent

Amendments to the terms of Finnair pension fund have a positive one-off impact of 85 million euros on Finnair’s Q4 operating result

Finnair Plc         Stock Exchange Release           28 October 2020 at 9.00 a.m. EET Certain amendments to the terms of Finnair pension fund have been approved. The amendments relate to pension index increment removals and are expected to have a positive one-off impact of 85 million euros on Finnair's operating result in Q4 2020. The impact will be reported as an item affecting comparability and, therefore, it has no effect on the comparable operating result. The amendments have no immediate cash flow impact, but the impact is deferred to future years. The amendments form a part of

Interim Report January - September 2020: Relevant, long-term partner

28 October 2020, 8.00 a.m. · Rental income increased by 6 percent to SEK 937.5 million (885.1). · Net operating surplus increased by 10 percent to SEK 753.1 million (681.9). · Profit from property management rose by 13 percent to SEK 542.5 million (478.0). · Profit for the period decreased to SEK 805.1 million (851.8), corresponding to earnings per share of SEK 21.36 (22.59), including changes in value of SEK 475.4 million (583.5). · Net asset value per share, EPRA NAV, increased to SEK 223.34 (194.07). Catena continues to deliver, generating strong cash flows with

There are no items matching the current filter
There are no more items matching the current filter
Back to top